Objective A subclavian artery aneurysm associated with Neurofibromatosis type 1 (NF 1) is extremely rare. We report a ruptured pseudo-aneurysm of the subclavian artery in a patient with NF 1 treated with endovascular surgery. Clinical description A 51 year old man with NF 1 presented with initially sudden left neck pain and continuous dysphagia. Radiological examination showed a pseudo-aneurysm of the left subclavian artery. Endovascular stenting and coil embolisation was performed to prevent rebleeding and the lesion was completely obliterated. Follow-up angiography at 3 months revealed good flow through the stent without flow into the pseudo-aneurysm. Conclusion Our patient is the first reported example of successful endovascular treatment for a ruptured subclavian artery pseudo-aneurysm associated with NF 1. Endovascular stenting and coil embolisation for the ruptured subclavian artery pseudo-aneurysm was very effective.
Introduction
Neurofibromatosis type 1 (NF 1) is an autosomal dominant disorder affecting one in 3,000-4,000 individuals [7] . Clinical features of NF 1 include multiple café-au-lait spots, benign neurofibromas, optic gliomas and iris hamartomas. Vascular abnormalities associated with NF 1 are rare and are reported to occur in 0.4-6.4% of patients [8] . The most common sites for arterial lesions are the aorta, the renal or cerebral circulations. The subclavian artery is rarely affected with only a few examples of dissection, aneurysmal dilatation or rupture recorded in the literature [8] . We report here a case of pseudo-aneurysm of the subclavian artery in a patient with NF 1 which was successfully treated with endovascular stenting and coil embolisation.
Clinical details
The patient was a 51 year old man with a diagnosis of NF 1. He presented with sudden left neck pain followed by continuous dysphagia and consulted a physician 3 days after onset of symptoms. The physical examination revealed neurofibromas and café-au-lait spots, typical of patients with NF 1. Neurological examination was normal.
The CT scan with contrast medium on admission showed a 3 cm aneurysm of the left subclavian artery (Fig. 1a) . A conventional angiogram 5 days after onset revealed an irregularly shaped, almost thrombosed aneurysm, 8.0× 5.0 mm, of the left subclavian artery compared with the aneurysm shown by enhanced CT (Fig. 1b) . The left vertebral artery was absent both on the CT and conventional angiograms. The right vertebral artery was patent on both angiograms. The lesion was described as a pseudo-aneurysm because the shape had changed with time. The left vertebral artery became occluded as the result of a dissection which probably caused the pseudo-aneurysm. Therefore, treatment with endovascular stenting and coil embolisation was planned to prevent rebleeding.
Endovascular treatment was performed under local anaesthesia 10 days after onset. The tip of a 6-Fr Shuttle sheath (Cook, Bjaeverskov, Denmark) was placed in the left subclavian artery proximal to the pseudo-aneurysm using the co-axial method via the right femoral artery and 4,000 units of heparin were intravenously administered for anticoagulation. Pre-operative angiography revealed that the aneurysm shape had changed further (Fig. 1c) . A 10× 20 mm Wallstent RP (Boston Scientific, Natick, MA) was positioned and deployed over the entire aneurysmal portion of the vessel (Fig. 1d) . A Prowler select LPES microcatheter (Cordis, Miami, FL) was inserted through the Shuttle sheath and its tip was positioned into the pseudoaneurysm cavity through the stent struts. A total of two detachable coils [Micrus CASHMERE (9×22 mm) and Micrus CASHMERE (7×17 mm); Micrus, San Jose, CA] were deployed into the pseudo-aneurysm cavity until it was completely obliterated (Fig. 1e) .
Ten days after endovascular treatment, the patient was discharged on Aspirin and Clopidogrel without neck pain and dysphagia. Follow-up angiography at 3 months revealed good flow through the stent without any filling of the pseudo-aneurysm. [10] is that the vasculopathy is caused by the alteration of the normal process of vascular maintenance and repair regulated by neurofibromin. Vascular abnormalities (arterial stenoses or aneurysms) in patients with NF 1 occur by a dynamic process of cellular proliferation, degeneration, healing, smooth muscle loss, and fibrosis [3] . Neurofibromin expression has been demonstrated in the vascular endothelial and smooth muscle cells [3] . The prevalence of vascular abnormalities associated with NF 1 is 0.4-6.4% [8] . Most patients with NF 1 vascular abnormalities are asymptomatic but have involvement of multiple vessels [8] . Oderich et al. [8] have reviewed 76 vascular abnormalities in 31 patients with NF 1. Arterial lesions were located in the aorta (n=17 lesions), renal (n=12), mesenteric (n=12), carotid-vertebral (n=10), intracerebral (n=4), subclavian-axillary and iliofemoral arteries (3 in each). An aneurysm of the subclavian artery occurred in only 1 (1.3%) of 76 vascular abnormalities. Furthermore, Oderich et al. [8] have reported a review of 237 patients with NF 1 from the English language literature who had 320 vascular abnormalities. Renal artery lesions were most common (41%) and were more often stenotic than aneurysmal. The carotid, vertebral, or cerebral artery lesions seen in 19% of patients were commonly aneurysms. Subclavian or innominate artery lesions (arterial aneurysms, dissection, rupture or stenoses) were seen in 6.3%.
Eleven examples of ruptured aneurysms of the subclavian artery in patients with NF 1, including ours (Table 1) , have been reported in the literature [5, 6, 9, [11] [12] [13] [14] [15] 17] . The mean age at the time of diagnosis was 43.4 years (range, 7-61 years), the left-side was more commonly affected and the incidence was almost equal in men and women. The clinical features of rupture included pain, haemothorax, expanding mass, dyspnoea and dysphagia. Thoracotomy, ligation, repair and grafting were performed as treatment of the ruptured aneurysm; four of 11 patients underwent ligation only. Most patients improved after surgical proximal ligation only, though some suffered from upper extremity ischaemia and gangrene. Therefore, ligation with grafting to re-establish blood flow to the extremity was also performed. However, surgical repair is aggressive and complex, and vessel reconstruction is limited by arterial fragility in patients with NF 1 [4] . In contrast, a combination of endovascular stenting and coil embolisation to prevent rebleeding and re-establish the blood flow peripherally has been reported in patients with external and internal carotid artery pseudo-aneurysm [2]. However, there has been no previously reported example of a ruptured subclavian artery aneurysm in a patient with NF 1 treated successfully with endovascular stenting and coil embolisation.
Self-expanding stents are used to treat carotid, subclavian and other peripheral artery pseudo-aneurysms. Furthermore, the combination of endovascular stenting and coil embolisation has been reported in patients with carotid artery pseudo-aneurysm [2] . Flexible stents may compress the pseudo-aneurysm inflow tract inducing stasis and facilitating intra-aneurysmal thrombosis, act as an endoluminal scaffold to prevent coil herniation into the parent artery allowing tight packing of even a wide-necked and irregularly shaped aneurysm and serve as a matrix for endothelial growth [1] . Assali et al. [1] evaluated the potential for using flexible self-expanding uncovered stents with or without coiling to treat extracranial internal carotid, subclavian and other peripheral artery post-traumatic pseudo-aneurysms. They concluded that uncovered endovascular flexible self-expanding stent placement with transstent coil embolisation of the pseudo-aneurysm cavity is a promising technique for treating such vascular disease by minimally invasive methods, while preserving the patency of the vessel and side branches [1] .
In our patient, we performed endovascular stenting and coil embolisation to prevent rebleeding and re-establish the blood flow to the extremity. Follow-up angiography revealed good flow through the stent without flow into the pseudo-aneurysm. We used Wallstent because the smaller cell size of this stent would be more helpful in reducing the blood flow into the pseudo-aneurysm and in preventing the herniation of coils into the parent artery. Although the use of covered stents may represent an alternative strategy in the endovascular treatment of aneurysms, we did not use covered stents due to the risk of side-branch compromise. Wallstents and other self-expandable stents, as such SMART stent (Cordis, Miami, FL), have been used for stent placement with or without coiling for pseudoaneurysms [1, 2] . Other self-expandable stents or covered stents might also be options for management of pseudoaneurysms. We conclude that endovascular stenting and coil embolisation appears to be a viable alternative to surgery.
